News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
859,177 Results
Type
Article (87414)
Company Profile (739)
Press Release (771006)
Multimedia
Podcasts (197)
Webinars (28)
Section
Business (232786)
Career Advice (4143)
Deals (39874)
Drug Delivery (144)
Drug Development (91179)
Employer Resources (205)
FDA (18256)
Job Trends (17422)
News (396884)
Policy (39843)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3002)
Academic (1)
Accelerated approval (31)
Adcomms (30)
Allergies (123)
Alliances (56809)
ALS (156)
Alzheimer's disease (1751)
Antibody-drug conjugate (ADC) (323)
Approvals (18397)
Artificial intelligence (474)
Autoimmune disease (155)
Automation (31)
Bankruptcy (402)
Best Places to Work (12515)
BIOSECURE Act (23)
Biosimilars (204)
Biotechnology (457)
Bladder cancer (145)
Brain cancer (53)
Breast cancer (557)
Cancer (4351)
Cardiovascular disease (303)
Career advice (3568)
Career pathing (41)
CAR-T (290)
CDC (36)
Celiac Disease (1)
Cell therapy (766)
Cervical cancer (29)
Clinical research (76209)
Collaboration (1635)
Company closure (4)
Compensation (994)
Complete response letters (64)
COVID-19 (2939)
CRISPR (85)
C-suite (738)
Cystic fibrosis (144)
Data (5501)
Decentralized trials (2)
Denatured (73)
Depression (120)
Diabetes (348)
Diagnostics (7004)
Digital health (25)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (254)
Drug pricing (161)
Drug shortages (19)
Duchenne muscular dystrophy (201)
Earnings (98120)
Editorial (57)
Employer branding (25)
Employer resources (173)
Events (132941)
Executive appointments (837)
FDA (20716)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (9)
Frontotemporal dementia (24)
Funding (1295)
Gene editing (184)
Generative AI (46)
Gene therapy (602)
GLP-1 (935)
Government (5323)
Grass and pollen (4)
Guidances (282)
Healthcare (20784)
HIV (43)
Huntington's disease (46)
IgA nephropathy (80)
Immunology and inflammation (267)
Immuno-oncology (58)
Indications (82)
Infectious disease (3160)
Inflammatory bowel disease (203)
Inflation Reduction Act (14)
Influenza (97)
Intellectual property (206)
Interviews (816)
IPO (17824)
IRA (45)
Job creations (5198)
Job search strategy (2866)
JPM (66)
Kidney cancer (16)
Labor market (92)
Layoffs (639)
Leadership (37)
Legal (10097)
Liver cancer (87)
Longevity (13)
Lung cancer (595)
Lymphoma (337)
Machine learning (41)
Management (66)
Manufacturing (734)
MASH (159)
Medical device (14480)
Medtech (14511)
Mergers & acquisitions (22766)
Metabolic disorders (1071)
Multiple sclerosis (151)
NASH (22)
Neurodegenerative disease (328)
Neuropsychiatric disorders (81)
Neuroscience (2915)
Neurotech (1)
NextGen: Class of 2026 (7686)
Non-profit (5079)
Now hiring (65)
Obesity (521)
Opinion (325)
Ovarian cancer (150)
Pain (157)
Pancreatic cancer (173)
Parkinson's disease (269)
Partnered (33)
Patents (409)
Patient recruitment (420)
Peanut (56)
People (66318)
Pharmaceutical (133)
Pharmacy benefit managers (20)
Phase 1 (23613)
Phase 2 (33161)
Phase 3 (24857)
Pipeline (4370)
Policy (283)
Postmarket research (3545)
Preclinical (10589)
Press Release (72)
Prostate cancer (205)
Psychedelics (51)
Radiopharmaceuticals (279)
Rare diseases (809)
Real estate (7423)
Recruiting (80)
Regulatory (28327)
Reports (64)
Research institute (2696)
Resumes & cover letters (651)
Rett syndrome (21)
RNA editing (21)
RSV (63)
Schizophrenia (140)
Series A (229)
Series B (167)
Service/supplier (26)
Sickle cell disease (88)
Special edition (27)
Spinal muscular atrophy (175)
Sponsored (47)
Startups (4323)
State (2)
Stomach cancer (15)
Supply chain (76)
Tariffs (76)
The Weekly (122)
Vaccines (1009)
Venture capital (93)
Weight loss (338)
Women's health (71)
Worklife (22)
Date
Last 7 days (483)
Last 30 days (1776)
Last 365 days (25813)
2026 (2431)
2025 (26119)
2024 (34309)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1280)
Alabama (86)
Alaska (6)
Arizona (290)
Arkansas (8)
Asia (51346)
Australia (9020)
California (9811)
Canada (2584)
China (1102)
Colorado (309)
Connecticut (393)
Delaware (295)
Europe (117074)
Florida (1261)
Georgia (256)
Hawaii (4)
Idaho (65)
Illinois (660)
India (62)
Indiana (445)
Iowa (21)
Japan (394)
Kansas (133)
Kentucky (25)
Louisiana (15)
Maine (59)
Maryland (1284)
Massachusetts (7385)
Michigan (246)
Minnesota (462)
Mississippi (5)
Missouri (80)
Montana (28)
Nebraska (29)
Nevada (106)
New Hampshire (58)
New Jersey (2620)
New Mexico (29)
New York (2582)
North Carolina (1427)
North Dakota (9)
Northern California (4814)
Ohio (258)
Oklahoma (18)
Oregon (51)
Pennsylvania (1881)
Puerto Rico (22)
Rhode Island (34)
South America (1658)
South Carolina (14)
South Dakota (1)
Southern California (3776)
Tennessee (58)
Texas (1364)
United States (34244)
Utah (228)
Vermont (1)
Virginia (211)
Washington D.C. (55)
Washington State (838)
West Virginia (2)
Wisconsin (84)
859,177 Results for "epic bio pte ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
YD Bio Limited Enters into Binding Letter of Intent to Acquire Safe Save Medical Cell Sciences & Technology Co., Ltd., Bolstering Leadership in Advanced Immunocell Therapy
January 29, 2026
·
6 min read
Press Releases
SL BIO Ltd. and Horizon Space Acquisition II Corp. Announce Registration Statement Effectiveness and Extraordinary General Meeting Date to Approve Business Combination
January 15, 2026
·
8 min read
Press Releases
Newly-formed Archerfish Precision Diagnostics Pte Ltd: Ushers a New Era in Advanced Diagnostics
March 6, 2025
·
5 min read
Press Releases
Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Bid Price Deficiency
January 19, 2026
·
4 min read
Sponsored
Taipei City Government Partners With Six Biotech Companies to Showcase at BIO International Convention 2025
The 2025 BIO International Convention (BIO2025), the world’s largest annual biotech event, will take place from June 16 to 19 (U.S. time) at the Boston Convention & Exhibition Center. This year, Taipei City Government is partnering with six Taipei-based biotech companies, including PanCAD.ai Co., Ltd., Instant NanoBiosensors Co., Ltd., Bened Biomedical Co., Ltd., Cancer Free Biotech Ltd., Xantho Biotechnology Co., Ltd., and Energenesis Biomedical Co., Ltd., to showcase their innovations at the Taiwan Pavilion (Booth #1645) in the Taipei Exhibition Area.
June 16, 2025
·
5 min read
Government
Congress Re-Introduces EPIC Act to Remove IRA’s ‘Pill Penalty’
While many industry players and observers have high hopes for the EPIC Act, some say budgetary headwinds could make it difficult for the current administration to make meaningful repeals or amendments to the IRA.
February 26, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Hinge Bio Announces License and Collaboration with Kyorin Pharmaceutical Co., Ltd. for the Development and Commercialization of HB2198 in Japan for Autoimmune Diseases
October 1, 2025
·
6 min read
Press Releases
vTv Therapeutics Amends License Agreement with Newsoara Biopharma Co. Ltd. for PDE4 inhibitor, HPP737
February 2, 2026
·
7 min read
Biotech Bay
Epic Bio to Present IND-Enabling Data Package for EPI-321 at FSHD International Research Congress
Epic Bio, a leading epigenetic editing company that plans to have its FSHD program enter the clinic this year, announced its participation in the upcoming FSHD International Research Congress being held June 13-14, 2024, in Denver, Colo.
June 7, 2024
·
2 min read
Biotech Bay
Epic Bio to Participate in a Fireside Chat at the Canaccord Genuity Genetic Medicine for Generalists
Epic Bio, a leading epigenetic editing company that plans to have its FSHD program enter the clinic this year, today announced that Amber Salzman, Ph.D., chief executive officer, participated in a fireside chat at the Canaccord Genuity - Genetic Medicine for Generalists Fireside Chat today.
April 10, 2024
·
1 min read
1 of 85,918
Next
